Sarosh Nagar joins Ethics Talk to discuss his article, coauthored with Drs Leah Z. Rand and Aaron S. Kesselheim: “What Should US Policymakers Learn From International Drug Pricing Transparency Strategies?”

Dr Nisha M. Patel joins Ethics Talk to discuss her article, coauthored with Drs Jesse M. Ehrenfeld and Brian J. Miller: “What Should ‘Shopping’ Look Like in Actual Practice?”

Professor Michael R. Ulrich joins Ethics Talk to discuss his article: “Why Money Is Well Spent on Time.”

Tension between realistic goals and unrealistic views about how to achieve them is compounded when patients are eager to revise a prior surgeon’s gender-affirming procedure.

Body mass index cutoffs are routinely used to assess eligibility for gender-affirming surgeries, yet they are not empirically based.

For dying patients and their loved ones to make informed decisions, physicians must share adequate information about prognoses, prospective benefits and harms of specific interventions, and costs.

Fragmentation in US health care delivery streams and shortcomings in formal quality measures mean that transparency could be more useful to policymakers and regulators than patients.

This article analyzes differences in prescription drug pricing transparency practices among 3 Organisation of Economic Co-operation and Development member nations.

There are a few reasons why incentivizing clinicians to spend more time with patients can improve health outcomes.

Dr Kimberly A. Singletary joins Ethics Talk to discuss her article, coauthored with Dr Marshall H. Chin: “What Should Antiracist Payment Reform Look Like?”